What is the treatment for Hirschsprung's disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Hirschsprung's Disease

The definitive treatment for Hirschsprung's disease is surgical resection of the aganglionic bowel segment with pull-through of normally innervated intestine to the anus. 1, 2

Surgical Management

Primary Surgical Approach

  • Surgery is the only curative treatment and involves removing the aganglionic segment and creating a ganglionated neorectum using proximal normally innervated bowel 1, 2
  • The procedure connects normally innervated bowel down to the anus while preserving sphincter function 2

Surgical Technique Options

Multiple established procedures are available, all with favorable outcomes 3, 2:

  • Transanal endorectal pull-through (TERPT): Minimally invasive one-stage procedure consisting of rectal mucosectomy, resection of aganglionic bowel, and colo-anal anastomosis 4, 3
  • Laparoscopic approaches: Associated with shorter hospital stays and favorable cosmetic results 3
  • Traditional procedures (Swenson, Soave, Duhamel): Well-established techniques that may include laparoscopic assistance 2

Critical Intraoperative Consideration

Frozen section evaluation of the entire circumference of the pull-through bowel is essential to confirm both ganglion cells and normal-caliber nerves are present, as the transition zone between aganglionic and ganglionic bowel is irregular 5

Post-Surgical Management

Common Post-Operative Problems

Even after successful surgery, patients may experience 1, 3:

  • Obstructive symptoms and constipation
  • Enterocolitis (most serious complication)
  • Fecal incontinence or soiling
  • Anastomotic stricture

Systematic Evaluation Approach for Post-Operative Symptoms

When symptoms persist after surgery, evaluate systematically for 1:

  • Anatomic factors: Examination under anesthesia, contrast studies, endoscopy
  • Inflammatory factors: Assessment for enterocolitis
  • Behavioral factors: Toileting patterns and habits
  • Motility factors: Anal sphincter function testing, colonic motility studies

Treatment of Post-Operative Complications

Medical management should be attempted first for most post-operative symptoms 1:

  • Sequential antibiotic therapy for bacterial overgrowth (similar principles as chronic intestinal failure management) 6
  • Bowel management programs tailored to specific symptoms
  • Botulinum toxin injection to anal sphincter for obstructive symptoms 1

Reoperation is rarely necessary but may be indicated when 1, 5:

  • Residual aganglionic or transition zone bowel is identified (found in 63% of reoperations) 5
  • Severe anatomic stricture is present
  • Medical management fails completely

Critical Pitfall to Avoid

Do not assume all post-operative bowel dysfunction is due to residual aganglionosis - multiple pathophysiological mechanisms can contribute, including sphincter dysfunction, motility disorders, and behavioral factors, each requiring different management strategies 1

Long-Term Follow-Up

Continued long-term monitoring is essential to assess 3:

  • Quality of life outcomes
  • Bowel function (constipation vs. incontinence)
  • Psychological well-being
  • Development of late complications like enterocolitis

References

Research

Hirschsprung's disease. Management.

Alimentary pharmacology & therapeutics, 2024

Research

Hirschsprung disease.

Nature reviews. Disease primers, 2023

Research

Transanal pull-through for Hirschsprung disease.

Seminars in pediatric surgery, 2005

Research

Reoperation for Hirschsprung disease: pathology of the resected problematic distal pull-through.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society, 2012

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.